OverviewChartNewsTraderScreen

UBS Call 81 AZN 21.03.2025/  DE000UM5NMD0  /

UBS Investment Bank
24/07/2024  21:50:08 Chg.+0.030 Bid- Ask- Underlying Strike price Expiration date Option type
0.640EUR +4.92% -
Bid Size: -		 -
Ask Size: -		 AstraZeneca PLC 81.00 - 21/03/2025 Call
TeleTrader 08/02 AstraZeneca sinks almost 7% after missing operating profit estimates
TeleTrader 22/12/2023 US FDA approves AstraZeneca-Ionis's medicine
TeleTrader 14/04/2022 Canada approves AstraZeneca's Evusheld
TeleTrader 20/05/2021 Japan health expert panel okays AZ, Moderna jabs
TeleTrader 08/03/2021 Italy okays AstraZeneca's vaccine for people over 65
TeleTrader 29/01/2021 Producing vaccines is a bumpy road - AZ's Soriot
TeleTrader 29/01/2021 AstraZeneca must deliver jabs from UK to EU - Von der Leyen
TeleTrader 29/01/2021 EU publishes vaccine contract with AstraZeneca
TeleTrader 27/01/2021 EU to 'defend investments' in AstraZeneca's vaccine
TeleTrader 25/01/2021 AstraZeneca's vaccine not effective in elderly people - report
TeleTrader 24/01/2021 EU to make firms respect vaccine delivery deadlines - Michel
TeleTrader 12/12/2020 AstraZeneca to acquire Alexion for $39B
TeleTrader 23/11/2020 Johnson: Months needed to perform inoculation
TeleTrader 01/11/2020 AstraZeneca's vaccine reviewed by UK regulator
TeleTrader 26/10/2020 AstraZeneca: Vaccine trial results 'encouraging'
TeleTrader 21/10/2020 Brazil says volunteer died during Oxford vaccine trial
TeleTrader 18/10/2020 We'll have more than one vaccine in 2021 - UK expert
TeleTrader 16/10/2020 Switzerland secures 5.3M doses of AstraZeneca's vaccine
TeleTrader 14/10/2020 US expands AstraZeneca treatment collaboration
TeleTrader 07/10/2020 AstraZeneca could up vaccine price in 2021 - report
TeleTrader 02/10/2020 AstraZeneca: Vaccine trial resumes in Japan
TeleTrader 23/09/2020 Fauci: By end of 2020 we'll know if vaccines effective
TeleTrader 23/09/2020 UBS: Vaccine approval in Q4 to shift stock markets
TeleTrader 20/09/2020 AstraZeneca's vaccine trial still on hold in US - company
TeleTrader 30/12/2019 FDA approves Astra Zeneca, Merck & Co. drug